Navigation Links
Presentation of Possible "Fountain of Youth" Pill Creating "Celebrity" Atmosphere at San Antonio Scientific Conference
Date:9/21/2012

SAN ANTONIO, Sept. 21, 2012 /PRNewswire/ -- The "Youth Pill" presentation won't happen until 6:00 p.m. this evening in the exhibit hall of the San Antonio Convention Center, but the Obesity Society's exclusive 30th Annual Meeting is buzzing with the same level of excitement normally reserved for a rock concert. Attendees at the conference — some of the world's most prestigious scientists — are eagerly awaiting the results of a research study conducted on an oral pill, in fact a dietary supplement called SeroVital™-hgh, developed by Sierra Research Group LLC, which may be capable of increasing serum (blood) growth hormone levels.

Some of the most cutting-edge obesity research in the world is being presented at this conference, so why is this particular presentation causing such a stir? Because HGH — which has been used for years by athletes seeking a competitive edge — has now gone mainstream as women and popular media outlets such as Dr. Oz, the Today Show, Fox News, CNN, Shape magazine, Vanity Fair, etc. have started discovering its touted benefits like reducing body fat, increasing lean muscle mass, boosting mood, strengthening bones, heightening sex drive, giving you plenty of energy and getting rid of wrinkles… making you look and feel decades — not years, but decades — younger.

For years, the only proven way to increase your growth hormone levels was through expensive prescription injections. But that may all be changing when tonight's research results are revealed. Those attending the conference realize that if there truly is an oral compound that can match the metabolic parameters of synthetic HGH injections, both the anti-aging and weight-loss industries could be completely revolutionized.

The presentation will take place this evening (Friday, September 21, 2012) from 6:00-7:30 p.m. in the Exhibit Hall of the San Antonio Convention Center.

To learn more contact Ariel Dunne at Behrman Communications: 212-986-7000 or adunne@behrmanpr.com

©2012 All Rights Reserved


'/>"/>
SOURCE Sierra Research Group LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. HeartWare Presentation at the UBS Global Life Sciences Conference to be Webcast
2. Agendia Announces Five Studies in Breast Cancer for Presentation at the American Society of Clinical Oncology 2012 Breast Cancer Symposium
3. Aethlon Medical Discloses MD Anderson Cancer Center Presentation
4. Thoratec Announces Presentations At Upcoming Investor Conferences
5. Orexigen Therapeutics Announces Presentations at Upcoming Investor Conferences
6. Regeneron Announces September 2012 Investor Conference Presentations
7. Volcano Corporation Presentation At Stifel Nicolaus Conference To Be Webcast
8. Cynosure Announces Upcoming Conference Presentations
9. InterMune Announces Presentations of New Research in IPF at ERS
10. ASQ to Give Free Presentation at MEDevice San Diego
11. HeartWare Presentation At The Canaccord Genuity 32nd Annual Growth Conference To Be Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... 19, 2017 Global Prostate Cancer Therapeutics ... the prostate cancer therapeutics market analyzes the current ... prevalence of prostate cancer, launch of promising emerging ... of new drugs & therapeutic biological products, and ... to lesser side effects are some of the ...
(Date:4/19/2017)... DIEGO , April 19, 2017  Sorrento ... an antibody-centric, clinical-stage biopharmaceutical company developing new treatments ... announced the closing of its previously announced underwritten ... stock at a public offering price of $2.00 ... and estimated offering expenses payable by Sorrento.  The ...
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-naïve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
Breaking Medicine Technology:
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... its new partnership with the Home Care Association of America (HCAOA). This agreement ... Private Duty Accreditation services, as well as discounts on Accreditation University (AU) educational ...
(Date:4/28/2017)... ... , ... Beginning in 2017, Ridgecrest Herbals will be phasing out the homeopathic ... Extra Strength formula. To ensure that the effectiveness of Clear Lungs Extra Strength is ... , Removal of the homeopathic element , Adding their patented ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. ... GlycoMark test throughout the Northeast U.S. , GlycoMark is the only clinically ... GlycoMark test provides a clinically proven one- to two-week measure of hyperglycemic excursions, ...
(Date:4/28/2017)... Fairfax, VA (PRWEB) , ... April 28, 2017 , ... ... elected volunteer board members and officers for 2017-2018. The annual board election process has ... serving on a volunteer basis. , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, ...
(Date:4/28/2017)... ... , ... The Texas Cord Blood Bank (TCBB), a program of nonprofit biomedical ... Women’s Hospital at Renaissance in Edinburg for their outstanding efforts in collecting umbilical cord ... donate. , “Women’s Hospital at Renaissance has been a collection partner for the ...
Breaking Medicine News(10 mins):